| CASE REPORT |
|
| Year : 2017 | Volume
: 5
| Issue : 1 | Page : 48-51 |
|
|
Role of Pippalyadi dietary herbs in Dyslipidemia as a risk reducer in cardio-vascular disease
Sonal Wankhede1, Sumeeta Jain2, VG Patrikar3, Yogesh Jakhar4, Nitesh Kamble5
1 PG Scholar, Dept of swasthavritta & yoga, GAC, Nagpur, India
2 Associate Professor, Dept of Swasthavritta & Yoga, GAC, Nagpur, India
3 Professor, Dept of swasthavritta & Yoga, GAC, Nagpur, India
4 PG Scholar, Dept of Swasthavritta & Yoga, GAC, Nagpur, India
5 Assistant professor, Dept of Sharir kriya, Parul institute of Ayurveda, Parul, Gujrat, India
Correspondence Address:
Sonal Wankhede
PG Scholar, Dept of swasthavritta & yoga, GAC, Nagpur
India
 Source of Support: None, Conflict of Interest: None
|
|
|
The present case study on a patient of dyslipidemia was conducted to evaluate the effect of dietary herbs on the lipid level which helps to prevent cardio-vascular risk. Ayurvedic literature mentions uses of dietary ingredients in the form of medicines instead of therapeutic formulations, which proves beneficial as an adjuvant therapy in curing ailments and reducing the risk of major diseases. In the present context, four drugs in the form of Pippalyadi dietary herbs were taken. The above formulation was given to the patient who was diagnosed a high risk candidate of developing a cardio-vascular disease for about 2 months after meals twice a day. The objective criteria taken for assessment was weight in Kg, lipid profile, anthropometric measurements while subjective criteria for assessment was hunger, thirst, bowel habit etc. Results showed that there was a gradual decrease in the level of lipid along with decline of other symptoms. Changes were noticed in the following assessment criteria. BMI was reduced to 29.38 along with reduction in waist circumference by 4cm. Also, changes were observed in the total cholesterol, LDL and HDL levels. Intake of Pippalyadi dietary herbs in the form of micro-nutrients is quite effective in reducing the cholesterol/lipid levels and eventually preventing the risk of CVD.
|
|
|
|
| [PDF]* |
|
 |
|
